Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ACM Research Announces Participation in 13th Annual NYC Summit 2024
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing[...]
11/29/2024 | Press release | Distributed by Public on 11/30/2024 18:25
Please select the service you want to use:
Smartlinks | Fate Therapeutics Inc. | News | Health | Biotechnology | Technology | Biotechnology | Science | Biotechnology | Research | Company News | Company Appointments | Corporate Officer Change | Securities Issuers | Biotechnology and Medical Research Companies | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact